SG11201806907XA - Obesity risk diagnosis kit and method for analyzing risk of obesity onset - Google Patents

Obesity risk diagnosis kit and method for analyzing risk of obesity onset

Info

Publication number
SG11201806907XA
SG11201806907XA SG11201806907XA SG11201806907XA SG11201806907XA SG 11201806907X A SG11201806907X A SG 11201806907XA SG 11201806907X A SG11201806907X A SG 11201806907XA SG 11201806907X A SG11201806907X A SG 11201806907XA SG 11201806907X A SG11201806907X A SG 11201806907XA
Authority
SG
Singapore
Prior art keywords
obesity
risk
analyzing
onset
diagnosis kit
Prior art date
Application number
SG11201806907XA
Other languages
English (en)
Inventor
Satoko ARATANI
Hidetoshi Fujita
Toshihiro Nakajima
Original Assignee
Watahiki Hajime
Toshihiro Nakajima
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Watahiki Hajime, Toshihiro Nakajima filed Critical Watahiki Hajime
Publication of SG11201806907XA publication Critical patent/SG11201806907XA/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/502Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing non-proliferative effects
    • G01N33/5023Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing non-proliferative effects on expression patterns
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6893Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00Oligonucleotides characterized by their use
    • C12Q2600/158Expression markers
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00Detection or diagnosis of diseases
    • G01N2800/04Endocrine or metabolic disorders
    • G01N2800/044Hyperlipemia or hypolipemia, e.g. dyslipidaemia, obesity

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biotechnology (AREA)
  • Analytical Chemistry (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Genetics & Genomics (AREA)
  • Microbiology (AREA)
  • Physics & Mathematics (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pathology (AREA)
  • General Engineering & Computer Science (AREA)
  • Cell Biology (AREA)
  • General Physics & Mathematics (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Biophysics (AREA)
  • Plant Pathology (AREA)
  • Toxicology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
SG11201806907XA 2016-03-15 2017-03-13 Obesity risk diagnosis kit and method for analyzing risk of obesity onset SG11201806907XA (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2016051038 2016-03-15
PCT/JP2017/009903 WO2017159592A1 (ja) 2016-03-15 2017-03-13 肥満リスクの診断キット,及び肥満の発症リスクの分析方法

Publications (1)

Publication Number Publication Date
SG11201806907XA true SG11201806907XA (en) 2018-09-27

Family

ID=59851484

Family Applications (1)

Application Number Title Priority Date Filing Date
SG11201806907XA SG11201806907XA (en) 2016-03-15 2017-03-13 Obesity risk diagnosis kit and method for analyzing risk of obesity onset

Country Status (8)

Country Link
US (1) US20190078074A1 (zh)
EP (1) EP3431594A1 (zh)
JP (1) JPWO2017159592A1 (zh)
CN (1) CN108779454A (zh)
AU (1) AU2017234903A1 (zh)
CA (1) CA3014526A1 (zh)
SG (1) SG11201806907XA (zh)
WO (1) WO2017159592A1 (zh)

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1666607A4 (en) * 2003-07-31 2007-11-21 Banyu Pharma Co Ltd METHOD OF EVALUATING AN EFFECTIVE COMPOUND FOR TREATING OBESITY USING SLC25A10
JP5804599B2 (ja) * 2009-05-13 2015-11-04 国立研究開発法人理化学研究所 内臓脂肪型肥満の検査薬およびその利用
US20130143748A1 (en) * 2010-05-27 2013-06-06 Sekisui Medical Co., Ltd. Methods for detection of risk of obesity and risk of onset of diabetes
JP6230546B2 (ja) * 2012-12-26 2017-11-15 中島 利博 肥満症の予防及び治療作用を有する化合物のスクリーニング方法

Also Published As

Publication number Publication date
CN108779454A (zh) 2018-11-09
CA3014526A1 (en) 2017-09-21
WO2017159592A1 (ja) 2017-09-21
US20190078074A1 (en) 2019-03-14
EP3431594A1 (en) 2019-01-23
AU2017234903A1 (en) 2018-08-30
JPWO2017159592A1 (ja) 2019-03-28

Similar Documents

Publication Publication Date Title
MX2015016047A (es) Metodo y sistema para mantener o mejorar el bienestar.
ATE554389T1 (de) Apex als marker für lungenkrebs
GB2488700B (en) Methods for monitoring disease conditions by analysis of the full repertoire of CDR3 sequences of an individual
EP3816303A3 (en) Breast cancer detection kit or device, and method for detecting breast cancer
NZ607282A (en) Method for using gene expression to determine prognosis of prostate cancer
EP3800253A3 (en) Prostate cancer detection kit or device, and detection method
EP4219765A3 (en) Prostate cancer prognosis using biomarkers
WO2014140933A8 (en) Method for the prognosis and treatment of cancer metastasis
MX2016003368A (es) Tecnicas de analisis de imagenes para diagnosis de enfermedades.
SG11201811263WA (en) Molecular marker, reference gene, and application and test kit thereof, and method for constructing testing model
HK1115636A1 (en) Use of cyfra 21-1 as a marker for colorectal cancer cyfra 21-1
WO2018007872A9 (en) Biomarkers for inflammatory bowel disease
WO2015131151A3 (en) Method and apparatus for determining markers of health by analysis of blood
MX2021012347A (es) Composiciones, metodos y kits para el diagnostico de una neoplasia neuroendocrina gastroenteropancreatica.
WO2015034886A3 (en) Wellness panel for companion animals
MX2018001697A (es) Método para la cuantificación de los miembros del filogrupo i y/o del filogrupo ii de faecalibacterium prausnitzii y el uso de los mismos como biomarcadores.
EA201490946A1 (ru) Способ количественной оценки лечения рака
EP2977467A3 (en) Method, use of marker, and determination device for obtaining information on plural types of cancers
MX2017014196A (es) Deteccion de factores de virulencia microbiana bucal.
EP3495502A3 (en) Biomarkers for premature birth
WO2009149319A3 (en) Gene expression profiles associated with asthma exacerbation attacks
BR112016028838A2 (pt) anticorpos, ácido nucleico, célula hospedeira, método de produção de um anticorpo, imunoconjugado, formulação farmacêutica, métodos de detecção de lgr5 humano em uma amostra biológica, de detecção de um câncer, de identificação de um paciente com câncer, de seleção de um paciente com câncer para tratamento com um imunoconjugado e de tratamento de um paciente com câncer
MX359376B (es) Metodo y kit para la determinacion de cobre libre en suero.
MX2016012278A (es) Deteccion temprana de preeclampsia.
ATE468535T1 (de) Verwendung von nnmt als marker für lungenkrebs